Agios Pharmaceuticals
AGIO
#5155
Rank
ยฃ1.16 B
Marketcap
ยฃ20.05
Share price
-0.62%
Change (1 day)
-28.33%
Change (1 year)

Revenue for Agios Pharmaceuticals (AGIO)

Revenue in 2025 (TTM): ยฃ33.95 Million

According to Agios Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is ยฃ32.72 Million. In 2024 the company made a revenue of ยฃ29.08 Million an increase over the revenue in the year 2023 that were of ยฃ21.05 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Agios Pharmaceuticals from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ33.95 M16.75%
2024 ยฃ29.08 M38.14%
2023 ยฃ21.05 M78.87%
2022 ยฃ11.77 M
2021 N/A-100%
2020 ยฃ32.31 M-64.06%
2019 ยฃ89.91 M20.93%
2018 ยฃ74.35 M133.65%
2017 ยฃ31.82 M-43.82%
2016 ยฃ56.64 M41.99%
2015 ยฃ39.89 M-4.97%
2014 ยฃ41.97 M171.04%
2013 ยฃ15.48 M-0.29%
2012 ยฃ15.53 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
ยฃ45.87 B 140,075.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ43.41 B 132,560.13%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ30.94 B 94,456.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
ยฃ0.12 B 273.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
ยฃ1.67 B 5,008.66%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ2.26 B 6,807.64%๐Ÿ‡บ๐Ÿ‡ธ USA